Research article summary (published 27 Feb 2006):

Stimulant medications: how to minimize their reinforcing effects?

Full Abstract

No abstract is available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.

Author information

Author/s: Volkow, Nora D (ND);

Journal and publication information

Publication Type: Comment; Editorial

Journal: The American journal of psychiatry (Am J Psychiatry), published in United States. (Language: eng)

Reference: 2006-Mar; vol 163 (issue 3) : pp 359-61

Dates: Created 2006/03/03; Completed 2006/04/25;

PMID: 16513852, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

Comments and Corrections

CommentOn: Am J Psychiatry. 2006 Mar;163(3):387-95. (PMID: 16513858)

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Attention Deficit Disorder with Hyperactivity - drug therapy; metabolism; psychology Behavior, Addictive - chemically induced; metabolism; psychology Brain - drug effects; metabolism Central Nervous System Stimulants - adverse effects; pharmacokinetics; therapeutic use Chemistry, Pharmaceutical Delayed-Action Preparations Dopamine - metabolism

Dopamine Plasma Membrane Transport Proteins - drug effects; metabolism Dose-Response Relationship, Drug Humans Methylphenidate - adverse effects; pharmacokinetics; therapeutic use Reinforcement (Psychology) Reward Substance-Related Disorders - etiology; metabolism; psychology

Associated Chemicals: Central Nervous System Stimulants (0) ; Delayed-Action Preparations (0) ; Dopamine Plasma Membrane Transport Proteins (0) ; Methylphenidate (113-45-1) ; Dopamine (51-61-6)

Related articles

These are the highest related articles currently in the database:

• Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient. 30 Dec 2002
• Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder. Dec 2007
• Mechanism of action of methylphenidate: insights from PET imaging studies. 30 Dec 2001
• Does chirality matter? pharmacodynamics of enantiomers of methylphenidate in patients with attention-deficit/hyperactivity disorder. 30 May 2008
• Impact of withdrawal of Ritalin LA in the Western Cape. 30 Jul 2008
• Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. 30 Oct 2003
• Pharmacokinetics and clinical effectiveness of methylphenidate. 29 Nov 1999
• Is there stimulant sensitivity in children? 30 Dec 2001
• Single-dose pharmacokinetics of multilayer-release methylphenidate and immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder. 27 Mar 2007
• Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder. 30 Mar 2007

See 100+ related articles.

Related Article Map

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.